INVESTIGADORES
BOLONTRADE Marcela Fabiana
artículos
Título:
Association of avb3 integrin expression with the metastatic potential and migratory and chemotactic ability of human osteosarcoma cells
Autor/es:
DUAN, XIAOPING; JIA, SHU-FANG; ZHOU, ZHICHAO; LANGLEY, ROBERT R.; BOLONTRADE, MARCELA F.; KLEINERMAN, EUGENIE S.
Revista:
CLINICAL & EXPERIMENTAL METASTASIS
Editorial:
SPRINGER
Referencias:
Lugar: Dordrecht; Año: 2005 vol. 21 p. 747 - 753
ISSN:
0262-0898
Resumen:
Introduction. Expression of adhesion molecules such as avb3 integrin has been associated with the metastatic potential of tumor cells. The purpose of this study was to determine whether avb3 expression correlated with the metastatic potential of human osteosarcoma cells. Materials and methods. We developed a series of sublines (LM2–LM7) from human osteosarcoma SAOS parental cells, with progressively increasing potential to form lung metastases in nude mice after intravenous injection. SAOS parental and LM2 cells were poorly metastatic, but LM7 cells resulted in visible metastatic lung nodules by 6–8 weeks. We quantified avb3 integrin expression using flow cytometry. Results. avb3 expression correlated with the metastatic potential of the cells, with LM7 cells showing the highest expression. LM7 cell adhesion to vitronectin decreased after treatment with echistatin, a RGD-containing peptide antagonist of avb3. LM7 cells demonstrated higher chemotactic activity than SAOS cells to a homogenate made from lung tissue. This chemotactic activity was also inhibited by echistatin. These data indicated that avb3 was critical for the migration of LM7 cells to the lung homogenate. Chemotaxis to a liver homogenate was the same for LM7 and SAOS cells. Migration of LM7 cells through lung endothelial cells was higher than that through liver endothelial cells, and echistatin again inhibited this migration. Conclusions. avb3 integrin expression may play a role in the metastatic potential of osteosarcoma cells by enhancing the ability of the cells to migrate specifically to the lung. avb3 integrin may therefore be a potential new target for osteosarcoma.